| Huntington disease: natural history, biomarkers and prospects for therapeutics CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ... Nature Reviews Neurology 10 (4), 204-216, 2014 | 1072 | 2014 |
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ... The Lancet Neurology 8 (9), 791-801, 2009 | 1063 | 2009 |
| Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ... The Lancet Neurology 12 (7), 637-649, 2013 | 957 | 2013 |
| Detection of Huntington’s disease decades before diagnosis: the Predict-HD study JS Paulsen, DR Langbehn, JC Stout, E Aylward, CA Ross, M Nance, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 874-880, 2008 | 949 | 2008 |
| A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length DR Langbehn, RR Brinkman, D Falush, JS Paulsen, MR Hayden, ... Clinical genetics 65 (4), 267-277, 2004 | 927 | 2004 |
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ... The Lancet Neurology 10 (1), 31-42, 2011 | 665 | 2011 |
| Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ... The Lancet Neurology 11 (1), 42-53, 2012 | 598 | 2012 |
| Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study K Duff, JS Paulsen, LJ Beglinger, DR Langbehn, JC Stout, ... Biological psychiatry 62 (12), 1341-1346, 2007 | 471 | 2007 |
| Neurocognitive signs in prodromal Huntington disease. JC Stout, JS Paulsen, S Queller, AC Solomon, KB Whitlock, JC Campbell, ... Neuropsychology 25 (1), 1, 2011 | 450 | 2011 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 438 | 2012 |
| CAG‐repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches DR Langbehn, MR Hayden, JS Paulsen, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010 | 438 | 2010 |
| Preparing for preventive clinical trials: the Predict-HD study JS Paulsen, M Hayden, JC Stout, DR Langbehn, E Aylward, CA Ross, ... Archives of neurology 63 (6), 883-890, 2006 | 396 | 2006 |
| Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ... The Lancet Neurology 16 (8), 601-609, 2017 | 364 | 2017 |
| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 317 | 2017 |
| fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s disease JS Paulsen, JL Zimbelman, SC Hinton, DR Langbehn, CL Leveroni, ... American Journal of Neuroradiology 25 (10), 1715-1721, 2004 | 316 | 2004 |
| Longitudinal change in regional brain volumes in prodromal Huntington disease EH Aylward, PC Nopoulos, CA Ross, DR Langbehn, RK Pierson, JA Mills, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (4), 405-410, 2011 | 305 | 2011 |
| Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients EJ Wild, R Boggio, D Langbehn, N Robertson, S Haider, JRC Miller, ... The Journal of clinical investigation 125 (5), 1979-1986, 2015 | 296 | 2015 |
| Striatal and white matter predictors of estimated diagnosis for Huntington disease JS Paulsen, PC Nopoulos, E Aylward, CA Ross, H Johnson, VA Magnotta, ... Brain research bulletin 82 (3-4), 201-207, 2010 | 268 | 2010 |
| Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease EH Aylward, AM Codori, A Rosenblatt, M Sherr, J Brandt, OC Stine, ... Movement disorders: official journal of the Movement Disorder Society 15 (3 …, 2000 | 257 | 2000 |
| Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population RJ Cadoret, D Langbehn, K Caspers, EP Troughton, R Yucuis, ... Comprehensive Psychiatry 44 (2), 88-101, 2003 | 249 | 2003 |
